Xilio Therapeutics
XLO
#9728
Rank
$34.83 M
Marketcap
$0.67
Share price
-1.00%
Change (1 day)
-54.22%
Change (1 year)

P/S ratio for Xilio Therapeutics (XLO)

P/S ratio as of April 2025 (TTM): 5.49

According to Xilio Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.98. At the end of 2024 the company had a P/S ratio of 7.01.

P/S ratio history for Xilio Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.01
2023N/A
2022N/A
2021N/A